We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MTB
76
Mizuho Trust & Banking
Japan
$24.8M +$25.9M +268,343 New
Principal Financial Group
77
Principal Financial Group
Iowa
$23.3M +$24.4M +252,853 New
Neuberger Berman Group
78
Neuberger Berman Group
New York
$22.7M +$23.7M +245,802 New
State of Wisconsin Investment Board
79
State of Wisconsin Investment Board
Wisconsin
$22.6M +$23.6M +244,614 New
NTCOC
80
Northern Trust Company of Connecticut
Connecticut
$22.3M +$23.3M +241,877 New
APG Asset Management
81
APG Asset Management
Netherlands
$22.1M +$23.1M +240,066 New
SG Americas Securities
82
SG Americas Securities
New York
$21.7M +$22.7M +235,719 New
BJ
83
BlackRock Japan
Japan
$21.3M +$22.2M +230,466 New
TI
84
Turner Investments
Pennsylvania
$21M +$22M +228,130 New
PAMU
85
Pictet Asset Management (UK)
United Kingdom
$19.6M +$20.4M +212,008 New
Swiss National Bank
86
Swiss National Bank
Switzerland
$19.2M +$20M +207,717 New
Dimensional Fund Advisors
87
Dimensional Fund Advisors
Texas
$19.1M +$20M +207,045 New
Citigroup
88
Citigroup
New York
$18.5M +$19.4M +201,014 New
PPA
89
Parametric Portfolio Associates
Washington
$18.5M +$19.3M +200,636 New
HCM
90
Highbridge Capital Management
New York
$18.3M +$19.2M +198,796 New
U
91
UBS
Switzerland
$17.9M +$18.7M +193,941 New
O
92
OrbiMed
New York
$17.8M +$18.6M +192,900 New
CCM
93
Century Capital Management
Massachusetts
$17.6M +$18.4M +191,021 New
MSA
94
Mason Street Advisors
Wisconsin
$17M +$17.7M +183,930 New
MTIP
95
Magee Thomson Investment Partners
California
$16.4M +$17.1M +177,818 New
TIM
96
Thornburg Investment Management
New Mexico
$16.3M +$17M +176,213 New
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
$16.2M +$16.9M +175,625 New
Barclays
98
Barclays
United Kingdom
$15.3M +$16M +166,052 New
Susquehanna International Group
99
Susquehanna International Group
Pennsylvania
$15.3M +$16M +165,672 New
USAA
100
United Services Automobile Association
Texas
$14.6M +$15.2M +158,202 New
2 3
4
5 6

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.